Edesa Biotech, Inc. Common Shares EDSA

$5.35 -1.47% at last close

Analyst Consensus

Consensus Rating
Buy (1 Buy · 0 Hold · 0 Sell)
Average Price Target
$5.00
Implied Upside
-6.5%
Price Target Range
$5.00 – $5.00
Analysts (12 mo)
1

Recent Analyst Actions

DateFirmActionRatingPrice Target
2025-11-03
HC Wainwright & Co.Yi Chen
Reiterates Buy $5
2025-06-27
HC Wainwright & Co.Yi Chen
Assumes Buy $5
2025-03-13
HC Wainwright & Co.Vernon Bernardino
Reiterates Buy $21
2024-08-20
HC Wainwright & Co.Vernon Bernardino
Reiterates Buy $21
2024-06-28
HC Wainwright & Co.Vernon Bernardino
Reiterates Buy $21
2024-02-14
HC Wainwright & Co.Vernon Bernardino
Reiterates Buy $21
2023-11-29
HC Wainwright & Co.Vernon Bernardino
Maintains Buy $70 → $21
2023-11-22
HC Wainwright & Co.Vernon Bernardino
Reiterates Buy $10
2023-10-12
Brookline CapitalKemp Dolliver
Maintains Buy $57
2023-08-15
HC Wainwright & Co.Vernon Bernardino
Maintains Buy $112 → $70
2023-05-24
HC Wainwright & Co.Vernon Bernardino
Reiterates Buy $112
2023-03-15
HC Wainwright & Co.Vernon Bernardino
Reiterates Buy $112
2023-02-14
HC Wainwright & Co.Vernon Bernardino
Reiterates Buy $112
2022-12-16
Brookline CapitalKemp Dolliver
Maintains Buy $13
2021-12-20
HC Wainwright & Co.Vernon Bernardino
Initiates coverage on Buy $112

Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.

Key Stats

Last Close
$5.35
Market Cap
$51.06 million
52-Week Range
$0.72 $20.32
Average Volume
55K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.